Showing results (481-490 of 495) with videos related to
Sort By:
Pageof 50
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification ProjectB N Nathwani, J R Anderson, J O Armitage, et al.Molekuliarnaia Biologiia|March 11, 2003
[Gene expression profiles of protein kinases and phosphatases obtained by hybridization with cDNA arrays: molecular portrait of human prostate carcinoma]Iu P Kniazev, Iu V Cheburkin, K Spikermann, et al.Blood|July 1, 1997
Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinaseI Rappold, B L Ziegler, I Köhler, et al.Cell|June 26, 2018
mTORC1 Controls Phase Separation and the Biophysical Properties of the Cytoplasm by Tuning CrowdingM Delarue, G P Brittingham, S Pfeffer, et al.Proceedings of the National Academy of Sciences of the United States of America|October 29, 1996
A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activityG Kéri, J Erchegyi, A Horváth, et al.Current Medicinal Chemistry|February 16, 2013
Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testingH K Ho, G Németh, Y R Ng, et al.Clinical Laboratory|September 5, 2009
Precision and long-term stability of different estradiol immunoassays assessed in a multi-center quality control studyJ Reinsberg, O Bätz, T Bertsch, et al.Nature|October 2, 1980
Human leukocyte interferon produced by E. coli is biologically activeD V Goeddel, E Yelverton, A Ullrich, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997
Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamideL K Shawver, D P Schwartz, E Mann, et al.Cancer Research|August 1, 1996
Flk-1 as a target for tumor growth inhibitionL M Strawn, G McMahon, H App, et al.Pageof 50